Novel PCR-EIA method for the detection of Chlamydia pneumoniae in respiratory specimens

Molecular and Cellular Probes

Volumn 16, Issue 1, 2002, Pages 57-61

  Inman Bamber, J ^a   Wan, C ^a   Gardam, T ^b   Vohra, R ^c   Van Daal, A ^a   Timms, P ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b PanBio Pty Limited   (Australia)

^c SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

Author keywords

Chlamydia pneumoniae; Chronic obstructive airways disease; PCR enzyme immunoassay

Indexed keywords

ANTIGEN DETECTION; ARTICLE; BACTERIAL INFECTION; BACTERIUM DETECTION; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLORIMETRY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; LABORATORY DIAGNOSIS; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROPREVALENCE; SPUTUM ANALYSIS;

CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 0036128058     PISSN: 08908508     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcpr.2001.0399     Document Type: Article

References (24)

1. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis
2. Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students
3. Chlamydia pneumoniae, strain TWAR pneumonia
4. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma
5. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis
6. Acute exacerbations in chronic obstructive pulmonary disease (COPD) -microbial patterns and risk factors
7. Chlamydia pneumoniae and cardiovascular disease
8. Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes
9. The role of Chlamydia pneumoniae in atherosclerosis - Recent evidence from animal models
10. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: The WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial
11. Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada)
12. Combining nucleic acid amplification and detection
13. Molecular diagnosis of Chlamydia pneumoniae infection
14. Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR
15. Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes
16. Detection of Chlamydia pneumoniae by polymerase chain reaction
17. Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene
18. A new primer pair for detection of Chlamydia pneumoniae by polymerase chain reaction
19. Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay
20. Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population
21. Comparison of a new commercial EIA kit and the microimmunofluorescence technique for the determination of IgG and IgA antibodies to Chlamydia pneumoniae
22. Solid-phase amplification and detection: A single-tube diagnostic assay for infectious agents
23. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections
24. Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: Feasibility study